This story tells you two things: (1) that I don't pay close attention to my finances, and (2) that Cingular has so confused its customers that they are paying or not paying a bevy of bills hoping to find some sort of normal rhythm....
Major biotech stocks have dropped after the discovery of unexpected drug side effects. Has the FDA been too lax?...
Some biochips barely cover a human thumbnail, but they can hold over a half of a million samples of DNA. The emerging technology has also found its place in protein research, the next step in studying disease....
Pedrus Pharma, a University of Wisconsin-Madison spinoff that has sped to the finals in the Governor's Business Plan Contest, may put a stop to the annual flu vaccine hoopla, among other things....
A real clunker slipped through the Assembly last week when it approved a bill to grant tax credits to innovative Wisconsin companies but snubbed a vital area of research....
Madison, Wis. — A drug-delivery patch took first place and $10,000 in the G. Steven Burrill Technology Business Plan Competition, the University of Wisconsin-Madison's annual contest for student entrepreneurs....
Badger Ventures, a newly forming venture capital firm, hopes to make waves in Madison and gather funding to invest in information technology companies. Plus: stem cells, BadgerNet....
How much do we Midwest tech employees think about the connections between our individual contributions and the company's profitability?...
Washington, D.C. — A full house packed the SEC headquarters for a public forum to discuss the most onerous section of The Sarbanes-Oxley Act of 2002....
The Federal Communications Commission is discussing how to rewrite the entire statute that governs how the agency works and how it regulates communications, said Kathleen Abernathy, an FCC Commissioner and graduate of Marquette University....